Loading clinical trials...

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan | Clinical Trials | Clareo Health

COMPLETEDPHASE3

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

NCT00212628•Ono Pharmaceutical Co. Ltd

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.

Eligibility

Age

55 - 80 years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•1. Patients who was included in study ONO-5920-02 and completed the medication for two years

Exclusion Criteria

•1. Patients judged to be unsuitable by safety evaluation as clinical trial subjects by the investigator
•2. Patients having secondary osteoporosis or another condition that presents low bone mass

Locations (9)

Chugoku Region Facility

Chugoku, Japan

Chubu Region Facility

Chūbu, Japan

Hokkaido Region Facility

Hokkaido, Japan

Hokuriku Region Facility

Hokuriku, Japan

Kanto Region Facility

Kanto, Japan

Kinki Region Facility

Kinki, Japan

Kyushu Region Facility

Kyushu, Japan

Shikoku Region Facility

Shikoku Region Facility, Japan

Tohoku Region Facility

Tōhoku, Japan

Key Dates

Start Date

June 1, 2004

Last Updated

June 14, 2012

Enrollment

444

ACTUAL participants

Conditions

Involutional Osteoporosis

Interventions

Minodronic acid hydrate

DRUG

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

NCT00212719

Involutional Osteoporosis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 14, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions